Labcorp to introduce combined oncology offering at 2021 asco® annual meeting

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced the introduction of its combined labcorp oncology platform at the virtual 2021 american society of clinical oncology (asco®) annual meeting held june 4-8. labcorp's oncology platform brings together the company's leadership in diagnostic testing with its comprehensive drug development services, delivering targeted solutions for oncology by leveraging breakthrough science and insights f
LH Ratings Summary
LH Quant Ranking